TGF-α-Driven Tumor Growth Is Inhibited by an EGF Receptor Tyrosine Kinase Inhibitor
- 11 January 2002
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 290 (1), 349-358
- https://doi.org/10.1006/bbrc.2001.6210
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- IMMUNOHISTOCHEMICAL COMPARATIVE ANALYSIS OF TRANSFORMING GROWTH FACTOR α, EPIDERMAL GROWTH FACTOR, AND EPIDERMAL GROWTH FACTOR RECEPTOR IN NORMAL, HYPERPLASTIC AND NEOPLASTIC HUMAN PROSTATESCytokine, 1999
- Expression of transforming growth factor-α and epidermal growth factor receptor in gastrointestinal stromal tumoursVirchows Archiv, 1999
- Autocrine Transforming Growth Factor α Provides a Growth Advantage to Malignant Cells by Facilitating Re-entry into the Cell Cycle from Suboptimal Growth StatesPublished by Elsevier BV ,1998
- Suppression of CD44 expression decreases migration and invasion of human glioma cellsInternational Journal of Cancer, 1996
- Anti-epidermal growth factor receptor monoclonal antibodies as potential anti-cancer agentsThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitorsJournal of Medicinal Chemistry, 1989
- Blocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase InhibitorsScience, 1988
- Discovering Order in Chaos: Stable Self-Organization of Neural Recognition CodesAnnals of the New York Academy of Sciences, 1987
- Human transforming growth factor-α: Precursor structure and expression in E. coliCell, 1984
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980